Passive Income Powerhouse Unveiled: The Ultimate Play!
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
Aby J. Mathew net worth and biography

Aby Mathew Biography and Net Worth

Dr. Mathew was part of the founding team of BioLife Solutions, Inc., and is a co-developer of BioLife’s biopreservation media solutions. He is a co-inventor on multiple issued and pending patents related to methods, devices, and formulations for the preservation of cells, tissues, and organs. He holds a Ph.D. in Biological Sciences within the Biochemistry, Cell and Molecular Biology Program from Binghamton University and a B.S. in Microbiology from Cornell University. Dr. Mathew has been researching low temperature biopreservation since 1994, and his studies contributed to the development of BioLife’s current commercial HypoThermosol® and CryoStor® product platforms and intellectual property foundation. Dr. Mathew was part of the scientific team that linked cell death via apoptosis (programmed cell death) to exposure to hypothermic and/or freezing temperatures. These discoveries were integral to the development of BioLife’s intracellular-like biopreservation media, and also contributed to improvements in cryosurgical ablation of cancer. Dr. Mathew was BioLife’s first Director of Manufacturing, established BioLife’s initial Quality system, and has been Executive Vice President & Chief Scientific Officer since December 2019. From February 2011 through November 2019, Dr. Mathew served as Senior Vice President & Chief Technology Officer. From January 2007 through February 2011, Dr. Mathew served as Senior Scientist, Director of Strategic Relations, and Senior Director of Strategic Relations. From June 2003 through January 2007, Dr. Mathew served as Director of Manufacturing. From September 2000 through June 2003, Dr. Mathew served as Clinical Accounts Manager and Director of Hypothermic Preservation for Cryomedical Sciences/BioLife Solutions. Dr. Mathew is currently active in, or previously a member of, AABB (formerly the American Association of Blood Banks), BEST (the Biomedical Excellence for Safer Transfusion collaborative), the International Society for Cell and Gene Therapy (ISCT), the Alliance for Regenerative Medicine (ARM), Tissue Engineering & Regenerative Medicine International Society (TERMIS), Society for Cryobiology, International Society for Biological and Environmental Repositories (ISBER), American Society for Cell Biology, and the Society for In Vitro Biology. Dr. Mathew is a member of: the Board of Directors, and Advisory Panel, of the Parent’s Guide to Cord Blood Foundation, the Scientific Advisory Board of HemaCare Corporation, the founding Board of Directors of the Cord Blood Association, the NIST-AMTech National Cell Manufacturing Consortium, the California Institute for Regenerative Medicine (CIRM) Clinical Advisory Panel, the Business Advisory Board of RoosterBio Inc., and the Scientific Advisory Board of SAVSU Technologies. Dr. Mathew has obtained UCLA Corporate Governance Program Certification

What is Aby J. Mathew's net worth?

The estimated net worth of Aby J. Mathew is at least $6.44 million as of May 31st, 2023. Dr. Mathew owns 272,614 shares of BioLife Solutions stock worth more than $6,436,417 as of June 7th. This net worth estimate does not reflect any other assets that Dr. Mathew may own. Learn More about Aby J. Mathew's net worth.

What is Aby J. Mathew's salary?

As the VP of BioLife Solutions, Inc., Dr. Mathew earned a total compensation package of $1,218,360.00 in 2021. Dr. Mathew earned a salary of $419,750.00, a bonus of $207,776.00, stock awards of $579,568.00, and other compensation of $11,266.00. Learn More on Aby J. Mathew's salary.

How do I contact Aby J. Mathew?

The corporate mailing address for Dr. Mathew and other BioLife Solutions executives is 3303 MONTE VILLA PARKWAY SUITE 310, BOTHELL WA, 98021. BioLife Solutions can also be reached via phone at (425) 402-1400 and via email at [email protected]. Learn More on Aby J. Mathew's contact information.

Has Aby J. Mathew been buying or selling shares of BioLife Solutions?

During the last quarter, Aby J. Mathew has sold $472,059.38 in BioLife Solutions stock. Most recently, Aby J. Mathew sold 504 shares of the business's stock in a transaction on Wednesday, May 31st. The shares were sold at an average price of $23.21, for a transaction totalling $11,697.84. Following the completion of the sale, the executive vice president now directly owns 272,614 shares of the company's stock, valued at $6,327,370.94. Learn More on Aby J. Mathew's trading history.

Who are BioLife Solutions' active insiders?

BioLife Solutions' insider roster includes Sarah Aebersold (VP), Todd Berard (CMO), Roderick de Greef (CFO), Karen Foster (Insider), Andrew Hinson (Director), Aby Mathew (VP), Michael Rice (CEO), Joseph Schick (Director), Marcus Schulz (CRO), and Troy Wichterman (CFO). Learn More on BioLife Solutions' active insiders.

Are insiders buying or selling shares of BioLife Solutions?

In the last twelve months, BioLife Solutions insiders bought shares 3 times. They purchased a total of 69,973 shares worth more than $1,501,559.78. In the last twelve months, insiders at the medical equipment provider sold shares 104 times. They sold a total of 267,557 shares worth more than $5,738,997.08. The most recent insider tranaction occured on May, 31st when EVP Aby J Mathew sold 504 shares worth more than $11,697.84. Insiders at BioLife Solutions own 3.3% of the company. Learn More about insider trades at BioLife Solutions.

Information on this page was last updated on 5/31/2023.

Aby J. Mathew Insider Trading History at BioLife Solutions

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/31/2023Sell504$23.21$11,697.84272,614View SEC Filing Icon  
5/24/2023Sell10,000$22.14$221,400.00273,118View SEC Filing Icon  
5/15/2023Sell125$18.71$2,338.75273,118View SEC Filing Icon  
4/19/2023Sell10,000$19.47$194,700.00268,352View SEC Filing Icon  
4/6/2023Sell2,093$20.03$41,922.79268,352View SEC Filing Icon  
3/29/2023Sell741$20.62$15,279.42270,445View SEC Filing Icon  
3/22/2023Sell10,000$21.44$214,400.00271,186View SEC Filing Icon  
3/7/2023Sell415$22.95$9,524.25271,186View SEC Filing Icon  
3/1/2023Sell2,086$22.75$47,456.50271,601View SEC Filing Icon  
2/9/2023Sell78$24.60$1,918.80273,687View SEC Filing Icon  
2/2/2023Sell10,000$24.85$248,500.00273,765View SEC Filing Icon  
1/3/2023Sell10,000$17.77$177,700.00252,826View SEC Filing Icon  
12/28/2022Sell712$16.90$12,032.80252,826View SEC Filing Icon  
11/29/2022Sell436$19.93$8,689.48253,538View SEC Filing Icon  
11/10/2022Sell107$23.16$2,478.12253,974View SEC Filing Icon  
9/29/2022Sell657$23.02$15,124.14254,081View SEC Filing Icon  
8/10/2022Sell112$23.17$2,595.04254,752View SEC Filing Icon  
6/28/2022Sell704$14.86$10,461.44253,015View SEC Filing Icon  
5/27/2022Sell351$14.53$5,100.03252,251View SEC Filing Icon  
5/13/2022Sell108$12.32$1,330.56251,816View SEC Filing Icon  
4/18/2022Sell19,325$17.59$339,926.75251,924View SEC Filing Icon  
3/29/2022Sell658$22.24$14,633.92View SEC Filing Icon  
3/1/2022Sell412$23.78$9,797.36View SEC Filing Icon  
2/10/2022Sell450$29.38$13,221.00View SEC Filing Icon  
2/2/2022Sell10,000$29.88$298,800.00View SEC Filing Icon  
1/5/2022Sell7,857$34.30$269,495.10View SEC Filing Icon  
12/29/2021Sell736$39.37$28,976.32View SEC Filing Icon  
12/8/2021Sell8,853$36.49$323,045.97View SEC Filing Icon  
12/6/2021Sell10,000$34.39$343,900.00View SEC Filing Icon  
11/17/2021Sell10,000$51.07$510,700.00View SEC Filing Icon  
11/15/2021Sell10,000$48.11$481,100.00View SEC Filing Icon  
10/20/2021Sell10,000$41.97$419,700.00View SEC Filing Icon  
10/18/2021Sell10,000$41.34$413,400.00View SEC Filing Icon  
10/14/2021Sell1,273$39.97$50,881.81View SEC Filing Icon  
9/28/2021Sell719$43.12$31,003.28View SEC Filing Icon  
9/22/2021Sell10,000$46.99$469,900.00View SEC Filing Icon  
9/20/2021Sell10,000$46.89$468,900.00View SEC Filing Icon  
8/27/2021Sell399$57.26$22,846.74View SEC Filing Icon  
8/25/2021Sell10,000$53.12$531,200.00219,589View SEC Filing Icon  
8/23/2021Sell10,000$46.54$465,400.00219,589View SEC Filing Icon  
7/21/2021Sell8,854$45.61$403,830.94219,589View SEC Filing Icon  
7/19/2021Sell10,000$43.85$438,500.00View SEC Filing Icon  
6/29/2021Sell715$43.75$31,281.25209,589View SEC Filing Icon  
6/16/2021Sell10,000$39.27$392,700.00220,304View SEC Filing Icon  
6/14/2021Sell10,000$38.90$389,000.00220,304View SEC Filing Icon  
5/28/2021Sell375$33.87$12,701.25210,304View SEC Filing Icon  
5/19/2021Sell10,000$31.45$314,500.00220,679View SEC Filing Icon  
5/17/2021Sell10,000$30.12$301,200.00220,679View SEC Filing Icon  
4/21/2021Sell20,000$32.44$648,800.00220,679View SEC Filing Icon  
4/19/2021Sell10,000$32.62$326,200.00220,679View SEC Filing Icon  
4/1/2021Sell4,020$36.53$146,850.60211,339View SEC Filing Icon  
3/26/2021Sell3,016$35.01$105,590.16200,981View SEC Filing Icon  
3/24/2021Sell10,000$40.18$401,800.00213,997View SEC Filing Icon  
3/22/2021Sell10,000$37.80$378,000.00213,997View SEC Filing Icon  
2/26/2021Sell403$39.57$15,946.71203,997View SEC Filing Icon  
2/19/2021Sell4,728$40.76$192,713.28185,313View SEC Filing Icon  
2/17/2021Sell4,640$41.55$192,792.00185,313View SEC Filing Icon  
2/4/2021Sell18,483$40.02$739,689.66198,905View SEC Filing Icon  
2/1/2021Sell18,484$38.71$715,515.64198,906View SEC Filing Icon  
12/1/2020Sell380$35.49$13,486.20180,422View SEC Filing Icon  
9/29/2020Sell1,858$28.63$53,194.54180,802View SEC Filing Icon  
9/23/2020Sell5,000$26.84$134,200.00182,660View SEC Filing Icon  
8/26/2020Sell255$20.48$5,222.40187,660View SEC Filing Icon  
8/11/2020Sell10,000$20.03$200,300.00192,915View SEC Filing Icon  
7/15/2020Sell10,000$19.48$194,800.00202,915View SEC Filing Icon  
5/28/2020Sell242$16.87$4,082.54212,915View SEC Filing Icon  
5/15/2020Sell10,000$14.29$142,900.00223,157View SEC Filing Icon  
5/13/2020Sell10,000$15.42$154,200.00223,157View SEC Filing Icon  
5/11/2020Sell10,000$13.40$134,000.00223,157View SEC Filing Icon  
3/24/2020Sell10,000$9.25$92,500.00179,562View SEC Filing Icon  
2/26/2020Sell1,024$15.02$15,380.48189,562View SEC Filing Icon  
5/14/2014Buy8,600$2.33$20,038.00View SEC Filing Icon  
See Full Table

Aby J. Mathew Buying and Selling Activity at BioLife Solutions

This chart shows Aby J Mathew's buying and selling at BioLife Solutions by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

BioLife Solutions Company Overview

BioLife Solutions logo
BioLife Solutions, Inc. engages in the development, manufacture and marketing of bio preservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs, generic blood stem cell freezing and cell thawing media products and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1987 and is headquartered in Bothell, WA.
Read More

Today's Range

Now: $23.61
Low: $23.58
High: $24.45

50 Day Range

MA: $20.35
Low: $17.19
High: $24.08

2 Week Range

Now: $23.61
Low: $12.60
High: $26.96


321,592 shs

Average Volume

304,529 shs

Market Capitalization

$1.03 billion

P/E Ratio


Dividend Yield